HIFs are involved in the pathogenesis and progression of many cancer types, including triple-negative breast and BRCA1-associated breast cancer, as they provide a growth advantage to rapidly growing tumours where angiogenesis may not be adequate. This evidence concerns the gene BRCA1 and breast cancer.